Ferring Pharmaceuticals Announces It Will Present Phase 3 Data for Cervical Ripening Agent at American College of Obstetricians and Gynecologist Annual Clinical Meeting
5/2/2013 10:13:27 AM
More...
|
Ferring Pharmaceuticals Data Suggest Lower Risk of Cardiovascular Events or Deaths in Prostate Cancer Patients Treated With Degarelix Compared to LHRH Agonists
3/18/2013 10:46:41 AM
More...
|
Ferring Pharmaceuticals to Highlight Phase 3 Data for Cervical Ripening Candidate at Society for Maternal-Fetal Medicine Annual Meeting
2/12/2013 9:12:51 AM
More...
|
Ferring Pharmaceuticals Recognized for Best-in-Class Work-Life Portfolio
1/31/2013 8:27:38 AM
More...
|
Now, Ferring Pharmaceuticals Challenges FDA Over Market Exclusivity
1/31/2013 7:35:43 AM
More...
|
Ferring Pharmaceuticals' European Marketing Authorization Application for Controlled Release Misoprostol Vaginal Delivery System for the Induction of Labor Accepted for Review
11/5/2012 10:54:43 AM
More...
|
Ferring Pharmaceuticals Announces FDA Acceptance of NDA Filing for Controlled Release Misoprostol Vaginal Insert for Decreasing Time to Vaginal Delivery in Women
10/23/2012 10:29:03 AM
More...
|
Ferring Pharmaceuticals Release: Study Results Show PREPOPIK™ (Sodium Picosulfate, Magnesium Oxide, and Anhydrous Citric Acid) Demonstrates Successful Colon Cleansing With the Lowest Active Prep Solution of Any Prescription Bowel Prep
10/23/2012 9:25:14 AM
More...
|
Ferring Pharmaceuticals Release: New Study Showed Desmopressin Melt Reduced Sleep Disruption in Bedwetting Children
10/12/2012 7:26:16 AM
More...
|
Walgreens Joins With Ferring Pharmaceuticals to Offer Products and Resources to Women Facing Fertility Complications From Cancer Treatment
9/6/2012 11:55:27 AM
More...
|
|